USSTOCK.TODAY
Market Closed
Log in Sign up

Axsome Therapeutics Revenue Growth · Moderna Sets $2.6 Billion Convertible Note Offering

The Motley Fool +1 · ·by G4L

AXSM
AXSM Axsome Therapeutics Inc
$149.24 +5.87%
View chart & analysis →
  1. 1Axsome's Auvelity recorded $180 million in revenue for the second quarter of 2026.
  2. 2Management forecasts peak sales for Axsome Auvelity to reach $8 billion.
  3. 3Moderna has set the offering price for its $2.6 billion convertible note offering.

So what's the key point?

Axsome's Auvelity recorded $180 million in revenue. Management expects this product's sales to reach $8 billion. Moderna has set the price for its $2.6 billion convertible note offering.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Caitlin Clark signs multi-year deal with Dick's Sporting Goods and Foot Locker CNBC +3 · Nov 5Axsome Therapeutics Inc. Third Quarter Results Beat Wall Street Estimates Associated Press · Nov 2Axsome Therapeutics Reports Third Quarter Results Exceeding Expectations Earnings Whispers · Nov 2
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news